Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adartrel 2mg tablets
0409010H0BCACAC
|
Adartrel | Ropinirole hydrochloride | Central Nervous System | 422 |
|
ReQuip 2mg tablets
0409010H0BBACAC
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 391 |
|
Spiroco XL 4mg tablets
0409010H0BDABAL
|
Spiroco XL | Ropinirole hydrochloride | Central Nervous System | 300 |
|
Ipinnia XL 3mg tablets
0409010H0BIABAR
|
Ipinnia XL | Ropinirole hydrochloride | Central Nervous System | 200 |
|
ReQuip 250microgram tablets
0409010H0BBAAAA
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 63 |
|
Ropiqual XL 2mg tablets
0409010H0BKAAAK
|
Ropiqual | Ropinirole hydrochloride | Central Nervous System | 52 |
|
ReQuip 5mg tablets
0409010H0BBADAD
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 50 |
|
Ropiqual XL 4mg tablets
0409010H0BKABAL
|
Ropiqual | Ropinirole hydrochloride | Central Nervous System | 37 |
|
Raponer XL 4mg tablets
0409010H0BGABAL
|
Raponer XL | Ropinirole hydrochloride | Central Nervous System | 36 |
|
Raponer XL 2mg tablets
0409010H0BGAAAK
|
Raponer XL | Ropinirole hydrochloride | Central Nervous System | 35 |
|
Raponer XL 8mg tablets
0409010H0BGACAM
|
Raponer XL | Ropinirole hydrochloride | Central Nervous System | 10 |
|
Ralnea XL 8mg tablets
0409010H0BEACAM
|
Ralnea XL | Ropinirole hydrochloride | Central Nervous System | 7 |
|
Ralnea XL 2mg tablets
0409010H0BEAAAK
|
Ralnea XL | Ropinirole hydrochloride | Central Nervous System | 6 |
|
Ralnea XL 4mg tablets
0409010H0BEABAL
|
Ralnea XL | Ropinirole hydrochloride | Central Nervous System | 3 |
|
Ropiqual XL 8mg tablets
0409010H0BKACAM
|
Ropiqual | Ropinirole hydrochloride | Central Nervous System | 3 |
|
Ropilynz XL 4mg tablets
0409010H0BJABAL
|
Ropilynz XL | Ropinirole hydrochloride | Central Nervous System | 1 |
|
Aimpart XL 2mg tablets
0409010H0BHAAAK
|
Aimpart XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Aimpart XL 4mg tablets
0409010H0BHABAL
|
Aimpart XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Aimpart XL 8mg tablets
0409010H0BHACAM
|
Aimpart XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Generic ReQuip tablets follow on pack
0409010H0AAAEAE
|
Ropinirole hydrochloride | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Generic ReQuip tablets starter pack
0409010H0AAAFAF
|
Ropinirole hydrochloride | Ropinirole hydrochloride | Central Nervous System | No data available |
|
ReQuip tablets follow on pack
0409010H0BBAEAE
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | No data available |
|
ReQuip tablets starter pack
0409010H0BBAFAF
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Ropilynz XL 2mg tablets
0409010H0BJAAAK
|
Ropilynz XL | Ropinirole hydrochloride | Central Nervous System | No data available |
|
Ropilynz XL 8mg tablets
0409010H0BJACAM
|
Ropilynz XL | Ropinirole hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.